BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 67837)

  • 1. Increased ocular and systemic responsiveness to epinephrine in primary open-angle glaucoma.
    Becker B; Montgomery SW; Kass MA; Shin DH
    Arch Ophthalmol; 1977 May; 95(5):789-90. PubMed ID: 67837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dipivefrin and epinephrine treatment of elevated intraocular pressure: a comparative study.
    Kass MA; Mandell AI; Goldberg I; Paine JM; Becker B
    Arch Ophthalmol; 1979 Oct; 97(10):1865-6. PubMed ID: 39539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacology of ocular drugs: 2. Epinephrine.
    Podos SM
    Ophthalmology; 1980 Jul; 87(7):721-3. PubMed ID: 7402600
    [No Abstract]   [Full Text] [Related]  

  • 4. Epinephrine as the initial therapy in selected cases of ocular hypertension.
    Podos SM; Ritch R
    Surv Ophthalmol; 1980; 25(3):188-94. PubMed ID: 7466598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Phospholine iodide and epitrate in glaucoma].
    Asayama R; Sakaue E; Ueno I; Maruyama K; Kondo T
    Nihon Ganka Kiyo; 1966 Feb; 17(2):229-40. PubMed ID: 6006621
    [No Abstract]   [Full Text] [Related]  

  • 6. Response to topical epinephrine. A practical prognostic test in patients with ocular hypertension.
    Becker B; Shin DH
    Arch Ophthalmol; 1976 Dec; 94(12):2057-8. PubMed ID: 999549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma.
    Kass MA; Heuer DK; Higginbotham EJ; Johnson CA; Keltner JL; Miller JP; Parrish RK; Wilson MR; Gordon MO
    Arch Ophthalmol; 2002 Jun; 120(6):701-13; discussion 829-30. PubMed ID: 12049574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose response analysis of 0.1 per cent, 0.5 per cent, 1.0 per cent, and 2.0 per cent epinephrine in chronic open-angle glaucoma.
    Tarkkanen A; Laatikainen L
    Acta Ophthalmol Suppl; 1974; 123():47-51. PubMed ID: 4368598
    [No Abstract]   [Full Text] [Related]  

  • 9. [Supersensitivity of outflow facility of epinephrine in open angle glaucoma treated with guanethidine].
    Takase M
    Nippon Ganka Gakkai Zasshi; 1970 Jan; 74(1):75-82. PubMed ID: 5462849
    [No Abstract]   [Full Text] [Related]  

  • 10. Therapeutic trial of the combination in an eye lotion of adrenaline (0.5 or 1%) and guanethidine (3 or 5%) in cases of open-angle glaucoma.
    Bardy M
    Ophthalmologica; 1979; 178(1-2):49-55. PubMed ID: 375150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Verification of the biphasic response in intraocular pressure during treatment of glaucoma patients with 3% guanethidine and 0.5% adrenaline.
    Hoyng PF
    Doc Ophthalmol; 1981 Mar; 51(1-2):161-73. PubMed ID: 7249915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical sympathectomy with 6-hydroxydopamine in the treatment of primary open-angle glaucoma.
    Kitazawa Y; Nosé H; Horie T
    Am J Ophthalmol; 1975 Jan; 79(1):98-103. PubMed ID: 1110209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Norepinephrine in treatment of ocular hypertension and glaucoma.
    Pollack IP; Rossi H
    Arch Ophthalmol; 1975 Mar; 93(3):173-7. PubMed ID: 1138682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A combination of 1% guanethidine and 0.2% epinephrine in drop form to lower IOP in open-angle glaucoma (author's transl)].
    van Husen H
    Klin Monbl Augenheilkd; 1980 Nov; 177(5):622-7. PubMed ID: 7253518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenalin therapy in glaucoma.
    Vannas S; Linkova M
    Acta Ophthalmol Suppl; 1973; 120():39-4. PubMed ID: 4359348
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparison of 0.1% dipivalyl epinephrine and 1% epinephrine in patients with glaucoma or ocular hypertension].
    Shao H; Sun XY; Bai FG
    Zhonghua Yan Ke Za Zhi; 1994 Mar; 30(2):104-7. PubMed ID: 8001439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical adrenergic potentiators in primary open-angle glaucoma.
    Kitazawa Y
    Am J Ophthalmol; 1972 Oct; 74(4):588-93. PubMed ID: 4403873
    [No Abstract]   [Full Text] [Related]  

  • 18. [New perspectives in glaucoma therapy with epinephrine and epinephrine derivatives (author's transl)].
    Adamek R
    Klin Monbl Augenheilkd; 1980 Jun; 176(6):978-81. PubMed ID: 7453024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative study between timolol and d-epinephrine in the treatment of open-angle glaucoma (author's transl)].
    Merkle W
    Klin Monbl Augenheilkd; 1981 Mar; 178(3):203-5. PubMed ID: 7014999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dose-response relationships of dipivalyl epinephrine in open-angle glaucoma.
    Krieglstein GK; Leydhecker W
    Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1978 Feb; 205(3):141-6. PubMed ID: 305728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.